Drug interactions
Octreotide + Tiotropium-olodaterol
Severity: Minor
Octreotide and Tiotropium-olodaterol: minor interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Octreotide can cause bradycardia and conduction disturbances with occasional QT prolongation, and olodaterol may add to arrhythmic risk through hypokalemia and tachycardia. The interaction is mainly theoretical for most patients.
What this interaction means in plain words
Octreotide and Tiotropium-olodaterol have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.
Octreotide belongs to Endocrine; Tiotropium-olodaterol belongs to Respiratory.
Why it happens
Possible additive effects on cardiac conduction and QT interval.
What to do
Monitor heart rate and ECG in patients with cardiac disease or other QT-prolonging drugs, and keep potassium and magnesium normal.
What to ask your pharmacist
- Is there anything I should notice while taking both?
- Do I need to tell my doctor at the next visit?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Octreotide and Tiotropium-olodaterol, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 14 days on the web. No card needed.
Other interactions of Tiotropium-olodaterol
Other interactions of Octreotide
Frequently asked questions
Can I take Octreotide with Tiotropium-olodaterol?
MediHelp rates the interaction as minor. Octreotide and Tiotropium-olodaterol have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Octreotide can cause bradycardia and conduction disturbances with occasional QT prolongation, and olodaterol may add to arrhythmic risk through hypokalemia and tachycardia. The interaction is mainly theoretical for most patients.
How serious is the interaction between Octreotide and Tiotropium-olodaterol?
MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor heart rate and ECG in patients with cardiac disease or other QT-prolonging drugs, and keep potassium and magnesium normal.
What other medicines interact with Tiotropium-olodaterol?
MediHelp also lists interactions of Tiotropium-olodaterol with, for example, Amisulpride, Arformoterol, Arsenic trioxide. The full list is on the Tiotropium-olodaterol page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
